Pelthos Therapeutics Inc.
PTHS
$23.06
-$0.14-0.60%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.66M | -16.24M | -3.45M | -1.97M | -1.93M |
| Total Depreciation and Amortization | 1.22M | 1.14M | -- | -- | -- |
| Total Amortization of Deferred Charges | 0.00 | 100.00 | 164.70K | 94.20K | 76.00K |
| Total Other Non-Cash Items | 18.41M | 4.87M | 413.50K | 485.80K | 530.00K |
| Change in Net Operating Assets | -4.22M | -5.03M | 2.42M | 755.40K | 650.00K |
| Cash from Operations | -6.25M | -15.26M | -447.10K | -632.10K | -670.00K |
| Capital Expenditure | -99.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -7.90M | 2.76M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -8.00M | 2.76M | -- | -- | -- |
| Total Debt Issued | 17.90M | 68.00K | 375.00K | 250.00K | -154.00K |
| Total Debt Repaid | 0.00 | -845.00K | -- | -- | 0.00 |
| Issuance of Common Stock | 121.00K | 85.00K | -- | -- | 83.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -75.00K |
| Issuance of Preferred Stock | 0.00 | 27.38M | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 74.00K |
| Cash from Financing | 18.02M | 26.69M | 375.00K | 250.00K | -72.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.77M | 14.19M | -72.10K | -382.10K | -742.00K |